Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWQWF peptide is a substance P (SP) antagonist (IC50 = 0.09 µM).1 It inhibits SP-induced activation of the neurokinin-1 (NK1) receptor, human MAS-related G protein-coupled receptor family member X2 (MRGPRX2), mouse MrgprB2, and mouse MrgprA1.2 QWF peptide inhibits contractions induced by SP (Item No. 24035; IC50 = 4.7 µM) but not histamine (Item No. 33828) in guinea pig tracheal strips.1 It also inhibits mast cell degranulation induced by SP, compound 48/80 (Item No. 22173), atracurium (Item No. 17796), or ciprofloxacin (Item No. 14286) in LAD 2 cells at 100 µM.2 QWF peptide reduces SP- or compound 48/80-induced itch in mice.
WARNING This product is not for human or veterinary use.
1. Studies on neurokinin antagonists. 1. The design of novel tripeptides possessing the glutaminyl-
2. Dual action of neurokinin-